Search Results - "Peña, C Gómez"

OHP-026 Prophylactic treatment of chronic migraine with botulinum toxin: study population by Fernández, C García, Peña, C Gómez, Rustarazo, S Belda, Delgado, A Rodriguez, Hidalgo, I Casas, Medina, MDC Gonzalez, Gómez, P Nieto

“…BackgroundIn different clinical studies, the use of botulinum toxin has shown a reduction in health spending, reducing the number of drugs used for patients…”
Get full text

CP-069 Evaluation of the effectiveness of fampridine and comparison with a clinical trial by Díaz-Villamarín, X, Fajardo, CL Dávila, Romero, R Morón, Medina, MDC González, Corpas, M Valle, Hidalgo, I Casas, Fernández, C García, Gómez-Peña, C, Cabeza-Barrera, J, Marín, C

“…BackgroundFampridine has been approved for improvement in walking capacity (WC) in multiple sclerosis adult patients with Expanded Disability Status Scale…”
Get full text

CP-200 Reactivation of hepatitis B after antineoplastic or immunosuppressive therapy by Fernández, C García, Peña, C Gómez, Romero, R Morón, Hidalgo, I Casas, Medina, MDC González, Corpás, M Valle, Rustarazo, S Belda, Fuentes, S Ruíz

“…BackgroundAdministration of immunosuppressive drugs can cause reactivation of hepatitis B virus (HBV), both asymptomatic and fulminant hepatitis. In July 2014,…”
Get full text

CP-191 Impact of medication reconciliation at hospital admission in surgical patients by Peña, C Gómez, Fernández, C García, Medina, MDC González, Corpas, M Valle, Romero, R Morón, Hidalgo, I Casas, Barrera, J Cabeza

“…BackgroundMedication reconciliation (MR) is known to minimise medicine errors and reduce morbidity in hospitalised patients. This process aims to identify and…”
Get full text

PP-041 Extemporaneous preparation of oral liquid formulation of capecitabina by Romero, R Morón, Corpas, M Valle, Medina, MDC González, Peña, C Gómez, Romero, A Caballero, Guardia, A Valle Ruiz de la, Delgado, A Rodriguez, Barrera, J Cabeza

“…BackgroundOncology patients often have swallowing problems or dysphagia. Dysphagia is a frequent syndrome in patients with tumours involving the CNS, head and…”
Get full text

2SPD-013 Economic impact of biosimilar infliximab use by García-Fernandez, C, Ruiz-Fuentes, S, Belda-Rustarazo, S, Gómez-Peña, C, Morón-Romero, R, Gómez-Nieto, P

“…BackgroundThe prescriptions of biologics are increasing as new indications and drugs are authorised. Since biosimilar drugs were introduced in the…”
Get full text

Integrated approaches for the assessment of health impacts of environmental chemicals: our experience in the GraMo cohort study by Arebola, J P, Martin-Olmedo, P, Pérez-Carrascosa, F M, León, J, Echeverría, R, Salcedo-Bellido, I, Gomez-Peña, C

“…Abstract The assessment of the health implications of human exposure to low doses of multiple environmental chemical pollutants represents an important…”
Get full text

Associations of serum phthalate metabolites with thyroid hormones in GraMo cohort, Southern Spain by Donat-Vargas, Carolina, Perez-Carrascosa, Francisco, Gomez-Peña, Celia, Mustieles, Vicente, Salcedo-Bellido, Inmaculada, Frederiksen, Hanne, Åkesson, Agneta, Arrebola, Juan Pedro

“…The general population is continuously exposed to phthalates via various consumer products. Epidemiological research relating phthalate exposure to thyroid…”
Get full text

Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults by Akinci, Muge, Peña-Gómez, Cleofé, Operto, Gregory, Fuentes-Julian, Sherezade, Deulofeu, Carme, Sánchez-Benavides, Gonzalo, Milà-Alomà, Marta, Grau-Rivera, Oriol, Gramunt, Nina, Navarro, Arcadi, Minguillón, Carolina, Fauria, Karine, Suridjan, Ivonne, Kollmorgen, Gwendlyn, Bayfield, Anna, Blennow, Kaj, Zetterberg, Henrik, Molinuevo, José Luis, Suárez-Calvet, Marc, Gispert, Juan Domingo, Arenaza-Urquijo, Eider M.

“…Increased anxious-depressive symptomatology is observed in the preclinical stage of Alzheimer disease (AD), which may accelerate disease progression. We…”
Get full text